NCT05630235View on ClinicalTrials.gov

Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
SCI - Spinal Cord InjuryNeuropathic Pain
Interventions
DRUG

CBD/CBD-A

Participants will be administered a one-time dose of 204.6 mg of CBD/CBD-A orally.

OTHER

Placebo

The placebo equivalent of the CBD/CBD-A dose administered orally.

Trial Locations (1)

33136

RECRUITING

Lynn Rehabilitation Center, Miami

All Listed Sponsors
collaborator

Consortium for Medical Marijuana Clinical Outcomes Research

OTHER

lead

University of Miami

OTHER